GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 133 filers reported holding GENOMIC HEALTH INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $213,000 | -12.0% | 4,233 | -40.1% | 0.00% | -50.0% |
| Q4 2017 | $242,000 | +272.3% | 7,063 | +181.3% | 0.00% | – |
| Q2 2016 | $65,000 | +18.2% | 2,511 | +14.0% | 0.00% | – |
| Q1 2016 | $55,000 | -6.8% | 2,203 | +32.1% | 0.00% | – |
| Q4 2015 | $59,000 | -89.6% | 1,668 | -93.8% | 0.00% | -100.0% |
| Q3 2015 | $566,000 | +3229.4% | 26,753 | +4222.0% | 0.00% | – |
| Q2 2015 | $17,000 | +13.3% | 619 | +28.7% | 0.00% | – |
| Q1 2015 | $15,000 | 0.0% | 481 | +3.7% | 0.00% | – |
| Q4 2014 | $15,000 | 0.0% | 464 | -14.5% | 0.00% | – |
| Q3 2014 | $15,000 | -6.2% | 543 | -6.5% | 0.00% | – |
| Q2 2014 | $16,000 | +6.7% | 581 | 0.0% | 0.00% | – |
| Q1 2014 | $15,000 | -11.8% | 581 | +1.8% | 0.00% | – |
| Q4 2013 | $17,000 | -71.7% | 571 | -70.7% | 0.00% | -100.0% |
| Q3 2013 | $60,000 | +81.8% | 1,948 | +86.1% | 0.00% | – |
| Q2 2013 | $33,000 | – | 1,047 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 13,770,982 | $433,648,000 | 3.55% |
| Camber Capital Management LP | 2,458,100 | $77,406,000 | 3.14% |
| EMORY UNIVERSITY | 76,851 | $2,420,000 | 2.28% |
| Tributary Capital Management, LLC | 294,962 | $9,288,000 | 0.91% |
| Motley Fool Asset Management LLC | 131,935 | $4,155,000 | 0.90% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 1,607,649 | $50,625,000 | 0.71% |
| UNIVERSITY OF NOTRE DAME DU LAC | 79,693 | $2,510,000 | 0.63% |
| Motley Fool Wealth Management, LLC | 129,245 | $4,070,000 | 0.39% |
| Spark Investment Management LLC | 189,700 | $5,973,000 | 0.38% |
| TFS CAPITAL LLC | 35,026 | $1,103,000 | 0.36% |